Cinclus Pharma Holding AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Gösta Hiller, was filed 08 Jun 2026.
Cinclus Pharma Holding AB (publ): what insiders have been doing
Every trade that managers of Cinclus Pharma Holding AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. In the past year (30 October 2025 to 30 October 2026), 8 filings came from 5 insiders.
No insider sold shares on the market over the period. Instead, the filings list 8 purchases totalling €100k, made by 5 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €46k, the purchase published on 15 December 2025 by Christer Ahlberg is the largest of the period. On the buying side, the filings list 2 board members, 1 finance chief and 1 senior executive among the declarants.
In all, 4 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (8 June 2026) now reads 153 days. Filings reach the Finansinspektionen feed a median of 3 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.
With 8 filings in twelve months, the company is quieter than the median of 9 filings across the 1,035 companies we follow on the same exchange. The full history, which starts in 2024, counts 33 purchases against no sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -2.6%Entry SEK 12.32 · Close 29 Oct 2026 SEK 12.00
- +0.7%Entry SEK 11.92 · Close 29 Oct 2026 SEK 12.00
- +0.7%Entry SEK 11.92 · Close 29 Oct 2026 SEK 12.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 shares@ SEK 12.380.0023% mcap33.7% of flowAktieISIN SE0020388577FI:A003Z677-1Canonical exit: 6 Sept 2026 (T+90)
- 13,000 shares@ SEK 12.10100.0% of flowAktieISIN SE0020388577FI:A003Z626-1Canonical exit: 2 Sept 2026 (T+90)
- 2,000 shares@ SEK 12.1466.3% of flowAktieISIN SE0020388577FI:A003Z635-1Canonical exit: 3 Sept 2026 (T+90)
- 7,000 shares@ SEK 12.180.016% mcap100.0% of flowAktieISIN SE0020388577FI:csv-f2e07aa136b7bb60c1a0Canonical exit: 13 Aug 2026 (T+90)
- 6,500 shares@ SEK 16.1055.4% of flowAktieISIN SE0020388577FI:csv-682e9fd4c0ad37183b17Canonical exit: 6 Jul 2026 (T+90)
- 5,600 shares@ SEK 18.4048.8% of flowAktieISIN SE0020388577FI:csv-8dc3d8c192383e948d18Canonical exit: 17 Jun 2026 (T+90)
- 6,000 shares@ SEK 17.970.020% mcap100.0% of flowAktieISIN SE0020388577FI:A003X228-1Canonical exit: 18 Jun 2026 (T+90)
- 29,000 shares@ SEK 17.132234.5% of flowAktieISIN SE0020388577FI:csv-d0dbc4fc853ee4895e46Canonical exit: 11 Mar 2026 (T+90)
- 40,000 shares@ SEK 15.901.7% of flowAktieISIN SE0020388577FI:csv-92d67803efecae4d4355Canonical exit: 21 May 2025 (T+90)
- 851,190 shares0AktieISIN SE0020388577FI:csv-9025638e4b03a5040211
- 851,191 shares0AktieISIN SE0020388577FI:csv-7d8a73f32b0fc2377f54
- 500 shares@ SEK 33.5011.8% of flowAktieISIN SE0020388577FI:csv-55d1ad7d8dd2f2b93dd6Canonical exit: 10 Oct 2024 (T+90)
- 2,635 shares@ SEK 42.0052.4% of flowAktieISIN SE0020388577FI:csv-169ba166edd498012e91Canonical exit: 18 Sept 2024 (T+90)
- 1,000 shares@ SEK 32.500.1% of flowAktieISIN SE0020388577FI:csv-843a18c9b17dde4cdad9Canonical exit: 23 Sept 2024 (T+90)
- 1,895 shares@ SEK 33.1044.7% of flowAktieISIN SE0020388577FI:csv-0264c0fe88e6971832d4Canonical exit: 23 Sept 2024 (T+90)
- 13,075 shares@ SEK 42.001.5% of flowAktieISIN SE0020388577FI:csv-cc3f86004652d9e24122
- 851,191 shares0AktieISIN SE0020388577FI:csv-3dc2ac72925034dcde7a
- 1,450 shares@ SEK 42.0043.5% of flowAktieISIN SE0020388577FI:csv-c1e530d31a1f73090e43Canonical exit: 18 Sept 2024 (T+90)
- 15,760 shares@ SEK 37.461.6% of flowAktieISIN SE0020388577FI:csv-f288e99f33e372ee67f4Canonical exit: 18 Sept 2024 (T+90)
- 9,690 shares@ SEK 39.18851.0% of flowAktieISIN SE0020388577FI:csv-a665f5398b38ba896174Canonical exit: 18 Sept 2024 (T+90)
- 2,490 shares@ SEK 42.000.3% of flowAktieISIN SE0020388577FI:csv-e831f64f17f07906e5a0Canonical exit: 18 Sept 2024 (T+90)
- 740 shares@ SEK 42.0027.0% of flowAktieISIN SE0020388577FI:csv-d11fa1358863acfc828aCanonical exit: 18 Sept 2024 (T+90)
- 370 shares@ SEK 42.0013.5% of flowAktieISIN SE0020388577FI:csv-d6c17d7fcd9ced53dbe0Canonical exit: 18 Sept 2024 (T+90)
- 1,000 shares@ SEK 34.5030.0% of flowAktieISIN SE0020388577FI:csv-f44ae8ef072aa8295272Canonical exit: 18 Sept 2024 (T+90)
- 1,000 shares@ SEK 34.0029.5% of flowAktieISIN SE0020388577FI:csv-beeb89c7a52b742d218dCanonical exit: 18 Sept 2024 (T+90)
25 of 45 declarations
About Cinclus Pharma Holding AB (publ)
Cinclus Pharma Holding AB (publ) is a pharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations